MRK vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
VS
Marvell Technology, Inc. · Technology
$133.37
+23.0% upside to fair value
High Conviction
Grade B
QuantHub Verdict
MRVL has more upside to fair value
(+23.0%).
MRK trades at a lower forward P/E
(22.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
MRVL |
| Current Price |
$114.27 |
$133.37 |
| Fair Value Estimate |
$118.00 |
$164.02 |
| Upside to Fair Value |
+3.3%
|
+23.0%
|
| Market Cap |
$282.2B |
$116.6B |
| Forward P/E |
22.4x
|
42.4x
|
| EV / EBITDA |
13.5x
|
—
|
| Price / Sales |
4.3x
|
14.2x
|
| Price / FCF |
20.2x
|
83.7x
|
| Revenue Growth YoY |
+5.0%
|
+7.0%
|
| Gross Margin |
81.9%
|
50.1%
|
| Operating Margin |
27.5%
|
16.3%
|
| Return on Equity |
5.6%
|
19.4%
|
| Dividend Yield |
2.91% |
— |
| FCF Yield |
4.95%
|
1.2%
|
| Analyst Consensus |
Overweight
|
Strong Buy
|
Investment Thesis
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
Accumulation Zones
| Metric |
MRK |
MRVL |
| Zone Low |
$88.50 |
$123.02 |
| Zone High |
$100.30 |
$139.42 |
| In Buy Zone? |
No
|
Yes
|